| Date | Title | Description | Source |
| 14.02.2024 | Replicate Bioscience Announces Positive Initial Clinical Res... | Replicate's srRNA vaccine elicited a protective immune response that met the WHO threshold for prote... | appletreep... |
| 10.07.2023 | Replicate Bioscience Appoints Rachael Lester as Chief Busine... | Biopharma executive with more than 20 years of global corporate, business development, and commercia... | appletreep... |
| 10.07.2023 | Replicate Bioscience Appoints Rachael Lester as Chief Busine... | Biopharma executive with more than 20 years of global corporate, business development, and commercia... | appletreep... |
| 26.07.2022 | Precision NanoSystems and Replicate Bioscience in Licensing ... | Companies aim to support development of up to 15 new genomic medicine products
Replicate’s commerci... | appletreep... |
| 26.07.2022 | Precision NanoSystems and Replicate Bioscience in Licensing ... | Companies aim to support development of up to 15 new genomic medicine products | appletreep... |
| 08.09.2021 | ATP Announces $40 Million in Series A Funding for srRNA Ther... | NEW YORK and SAN DIEGO, Sept. 8, 2021 /PRNewswire/ -- ATP, a leader in life sciences venture capital... | marketscre... |
| 08.09.2021 | ATP Announces $40 Million in Series A Funding for srRNA Ther... | NEW YORK and SAN DIEGO, Calif., September 8, 2021/PR NEWSWIRE/ – ATP, a leader in life sciences vent... | appletreep... |
| 08.09.2021 | ATP Announces $40 Million in Series A Funding for srRNA Ther... | NEW YORK and SAN DIEGO, Calif., September 8, 2021/PR NEWSWIRE/ – ATP, a leader in life sciences vent... | appletreep... |
| 08.09.2021 | ATP Announces $40 Million in Series A Funding for srRNA Ther... | | prnewswire... |
| 08.09.2021 |
Replicate Biosciences Gets $40M
| San Diego-based Replicate Bioscience, which is looking to use self-replicating RNA (srRNA) to treat ... | socaltech.... |
| 08.09.2021 | Replicate Bioscience Lands $40M in Series A |
SAN DIEGO, CA, Replicate Bioscience has raised $40 million in committed Series A.
>> Click ... | vcnewsdail... |
